Application Nr Approved Date Route Status External Links
ANDA076847 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Sumatriptan Tablets Are Indicated For The Acute Treatment Of Migraine Attacks With Or Without Aura In Adults. Sumatriptan Tablets Are Not Intended For The Prophylactic Therapy Of Migraine Or For Use In The Management Of Hemiplegic Or Basilar Migraine (See Contraindications ). Safety And Effectiveness Of Sumatriptan Tablets Have Not Been Established For Cluster Headache, Which Is Present In An Older, Predominantly Male Population.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sumatriptan Succinate SUMATRIPTAN SUCCINATE ZINC14360

Comments